Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire Arthrosi Therapeutics, a startup with a gout drug candidate in Phase 3 ...

The MarketWatch News Department was not involved in the creation of this content. -- Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients ...

October 2, 2012 — New gout guidelines from the American College of Rheumatology are meant to improve gout management by providing clinicians with clear, readily implemented guidance on urate-lowering ...

TikTok is overflowing with videos promising to “flush” uric acid, reverse gout overnight, or cure joint pain with a single ...

A widely available drug used for gout may help prevent heart attacks and stroke in people with cardiovascular disease. The corresponding review was published in the Cochrane Database of Systematic ...

A recent review found that low dose colchicine may help prevent heart attacks and strokes in individuals who already have cardiovascular disease. The review also found that colchicine likely doesn’t ...

A new study finds that TikTok videos about gout frequently spread confusing or inaccurate advice. Most clips focus on diet ...

In a 10-year propensity-matched cohort study, Irene Tan, MD, of the Einstein Healthcare Network and Jefferson Health in ...

A drug used to treat gout could reduce the risk of a heart attack or stroke, according to a new study. Researchers found colchicine - an inexpensive drug used to treat the painful type of arthritis - ...

Study finds that fewer patients with gout received useful colchicine drug after FDA actions led to 50x increase in price. Well intentioned, but costly and potentially problematic. That's how ...